Many patients with Hashimoto's disease struggle with weight management and metabolic challenges, leading to questions about whether GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) might help
Circulation 129 , E426E426 (2014)
Overall depression symptom severity was measured with the Inventory of Depressive Symptomatology self-report questionnaire (IDS-SR 30 ) [36,37,38], with scores ranging from 0 to 84
Improved Metabolic Health : In addition to helping you lose weight, our approach focuses on improving metabolic health by stabilizing blood sugar levels, enhancing insulin sensitivity, and reducing inflammation
We prioritize: Customized weight loss strategies integrating GLP-1 peptide therapy, nutrition, and fitness